FHIR IG analytics

Resources that use this resource

No resources found

Resources that this resource uses

No resources found

Narrative

Note: links and images are rebased to the (stated) source

Source1

{
  "resourceType": "ArtifactAssessment",
  "id": "179698",
  "meta": {
    "versionId": "5",
    "lastUpdated": "2024-12-12T13:30:04.381Z",
    "profile": [
      "http://hl7.org/fhir/uv/ebm/StructureDefinition/adaptation"
    ]
  },
  "language": "en",
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/artifact-author",
      "valueContactDetail": {
        "name": "Joanne Dehnbostel"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/artifact-description",
      "valueMarkdown": "This example of an Adaptation Profile shows the specific content that was changed when adapting one Recommendation Profile instance to create a new Recommendation Profile instance, serving a role of 'track changes' for structured data."
    },
    {
      "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
      "valueCodeableConcept": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
            "code": "active",
            "display": "Active"
          }
        ]
      }
    }
  ],
  "modifierExtension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/artifact-status",
      "valueCode": "active"
    }
  ],
  "identifier": [
    {
      "type": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code": "ACSN",
            "display": "Accession ID"
          }
        ],
        "text": "FEvIR Object Identifier"
      },
      "system": "https://fevir.net/FOI",
      "value": "179698",
      "assigner": {
        "display": "Computable Publishing LLC"
      }
    }
  ],
  "title": "Joanne Dehnbostel's Adaptation Report of Recommendation: ADA Obesity Management Recommendation 8.16",
  "artifactReference": {
    "reference": "Composition/179466",
    "type": "Composition",
    "display": "Recommendation: ADA Obesity Management Recommendation 8.16"
  },
  "content": [
    {
      "type": {
        "text": "adapted element"
      },
      "classifier": [
        {
          "coding": [
            {
              "system": "https://fevir.net/resources/CodeSystem/179423",
              "code": "string-datatype",
              "display": "string Datatype"
            }
          ]
        }
      ],
      "path": [
        "overallSummary"
      ],
      "component": [
        {
          "summary": "8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI ≥40 kg/m2 (BMI ≥37.5 kg/m2 in Asian Americans) and in adults with BMI 35.0–39.9 kg/m2 (32.5–37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods. A",
          "type": {
            "coding": [
              {
                "system": "https://fevir.net/resources/CodeSystem/179423",
                "code": "OriginalResourceContent",
                "display": "Original Resource Content"
              }
            ]
          }
        },
        {
          "type": {
            "coding": [
              {
                "system": "https://fevir.net/resources/CodeSystem/179423",
                "code": "RationaleForChange",
                "display": "Rationale for Change to Resource Content"
              }
            ]
          },
          "classifier": [
            {
              "coding": [
                {
                  "system": "https://fevir.net/resources/CodeSystem/179423",
                  "code": "suggested-change",
                  "display": "Suggested change"
                }
              ]
            }
          ]
        },
        {
          "summary": "8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI ≥40 kg/m2 (BMI ≥37.5 kg/m2 in Asian Americans) and in adults with BMI 35.0–39.9 kg/m2 (32.5–37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.",
          "type": {
            "coding": [
              {
                "system": "https://fevir.net/resources/CodeSystem/179423",
                "code": "SuggestedChange",
                "display": "Suggested Change to Resource Content"
              }
            ]
          }
        }
      ]
    }
  ]
}